dipyridamole has been researched along with Aqueductal Stenosis in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lereboullet, J | 1 |
| Rosa, A | 1 |
| Olivier-Martin, R | 1 |
| Stuart, M | 1 |
| Stockman, J | 1 |
| Murphy, S | 1 |
| Schut, L | 1 |
| Ames, M | 1 |
| Urmson, J | 1 |
| Oski, F | 1 |
2 other studies available for dipyridamole and Aqueductal Stenosis
| Article | Year |
|---|---|
[Neuropsychiatry in 1973].
Topics: Aspirin; Bipolar Disorder; Dipyridamole; Heart Diseases; Humans; Hydrocephalus; Hypoxia, Brain; Isch | 1973 |
Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: results of preliminary attempts at correction.
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Catheterization; Cerebral Ventricles; Cerebrospin | 1972 |